Navigation Links
NovaBay announces third quarter 2007 financial results
Date:11/15/2007

er associated urinary

tract infections, a significant source of hospital-associated

infections. An Investigational New Drug application for this

indication is expected to be filed with the FDA before the end of

2007.

During the third quarter of 2007, NovaBay continued its work to

develop its Aganocide compounds with its partner, an affiliate of

Alcon, Inc., for use in the treatment of infections in the eye, ear

and sinus and in contact lens solutions.

About NovaBay

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative product candidates targeting the treatment or prevention of a wide range of infections in hospital and non-hospital environments. NovaBay has discovered and is developing a class of non-antibiotic anti-infective compounds, which it has named Aganocide compounds, which are based upon small molecules that are generated by white blood cells that defend the body against invading pathogens. NovaBay believes that Aganocide compounds could form a platform on which to create a variety of products to address differing needs in the treatment and prevention of bacterial and viral infections, including Methicillin-Resistant Staphylococcus aureus (MRSA). NovaBay has entered into a licensing and research collaboration agreement with an affiliate of Alcon, Inc. for use of the Aganocide compounds in the eye, ear and sinus and in contact lens solutions and a license agreement with an affiliate of Kinetic Concepts, Inc. for the use of NovaBay's NeutroPhase product in woundcare applications.

NovaBay(TM) , Aganocide(TM) and NeutroPhase(TM) are trademarks of NovaBay

Pharmaceuticals, Inc. All other trademarks and trade names are the

property of their respective owners.

Forward Looking Statements

This release contains forward-looking statements, which are based upon management's current expectations, assumptions,
'/>"/>

SOURCE NovaBay Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. NovaBay Pharmaceuticals Closes Initial Public Offering of Common Stock
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... July 07, 2015 , ... Researchers at UC ... what worked (or didn’t) and how similar programs can be improved. , Interviewing ... Living TeleHealth Community of Practice (HEALTH COP) program, the team identified four factors ...
(Date:7/7/2015)... ... July 07, 2015 , ... WiseWear®, a ... launched their first line of luxury smart jewelry called the Socialite™ collection. The ... ship this fall. , “The Socialite collection was crafted to inspire women ...
(Date:7/7/2015)... ... 2015 , ... Dermatologists from the Mount Sinai Health System ... possible melanomas and 46 potential non-melanoma skin cancers (basal cell and squamous cell ... Ideas Festival, which was held from June 25 through July 4, 2015, in ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... announced today that the two firms have merged to form Camber Collective. ... and biopharma sectors. The merger combines SwitchPoint’s strategy consulting expertise with Hope ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... group whose board is limited to permit holders. The Medical Cannabis Alliance of ... move the industry forward and are committed to making sure patients have access ...
Breaking Medicine News(10 mins):Health News:UC Davis Study Identifies Tools, Strategies for Enhancing Obesity Prevention in Rural Communities 2Health News:UC Davis Study Identifies Tools, Strategies for Enhancing Obesity Prevention in Rural Communities 3Health News:WiseWear Unveils Luxury Smart Jewelry Line 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 4Health News:SwitchPoint and Hope Consulting Have Merged to Form Camber Collective 2Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2
... 11 The Chasen Group ... ergonomic interventions to prevent workplace injuries, increase employee ... Wiley and Sons, the foremost publisher of scientific ... "Safety Manager,s Guide to Office Ergonomics," written by ...
... an invited panelist in the second annual SOA in Healthcare conference to ... ... Plano, Texas (PRWEB) May 11, 2009-- Corepoint Health,s CTO, Dave Shaver, will ... to be held on June 2 - 4 in Chicago, Illinois. ...
... new alternative for patientsRESEARCH TRIANGLE PARK, N.C., May 11 ... that the U.S. Food and Drug Administration (FDA) has ... ODT uses a novel drug-delivery formulation to provide ... pleasant taste and disintegrates on the tongue. One ...
... RAPIDS, Mich., May 11 Lambert, Edwards ... Inc. to its growing roster of health care clients.Aspirus ... Wis. providing health care services to residents in north-central ... Aspirus Wausau Hospital is consistently recognized as one of ...
... ProCitius Research jointly announce a strategic alliance created to provide clients ... ... Toronto, Canada and Chennai, India (PRWEB) - Dalton Pharma Services and ... with contract chemistry services of exceptional value. , ...
... During National Women,s Health Week Points to Importance of ... today on gender-based differences in mental health shows women ... from major depression. The report addresses many other ... and violence can have on long term mental health, ...
Cached Medicine News:Health News:Office Ergonomics Book Reveals Early-Stage Solutions 2Health News:Corepoint Health CTO to Participate in Panel Discussion at the 2009 SOA in Healthcare Conference 2Health News:Corepoint Health CTO to Participate in Panel Discussion at the 2009 SOA in Healthcare Conference 3Health News:FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets 2Health News:FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets 3Health News:FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets 4Health News:FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets 5Health News:FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets 6Health News:Lambert, Edwards & Associates Named Agency of Record for Aspirus, Inc. 2Health News:Dalton Pharma Services and ProCitius Announce a Strategic Alliance to Provide Contract Chemistry Services 2Health News:Dalton Pharma Services and ProCitius Announce a Strategic Alliance to Provide Contract Chemistry Services 3Health News:Women at Greater Risk for Depression and Anxiety 2Health News:Women at Greater Risk for Depression and Anxiety 3
(Date:7/7/2015)... International Corporation (NASDAQ: PRXL ) will release financial results ... August 5 th , 2015 after the close of the ... at www.PAREXEL.com and on the PRNewswire website at ... call and live webcast at 10:00 a.m. EDT on Thursday, ... access the webcast, visit PAREXEL,s website at www.PAREXEL.com , ...
(Date:7/7/2015)... , July 7, 2015   InspireMD, ... "Company"), a leader in embolic protection systems ("EPS"), ... Embolic Protection System integrated with MicroNet ™ ... Coronary Stent New Product Innovation Award.  Through active ... of analysts and consultants recognize the successful introduction ...
(Date:7/7/2015)... Minn. , July 7, 2015 EnteroMedics ... of devices that use neuroblocking technology to treat obesity, ... of its previously announced public offering of 32,000,000 units. Each ... one Series A warrant to purchase one share of ... unit. Investors whose purchase of units in the offering ...
Breaking Medicine Technology:PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2015 Earnings Release And Conference Call 2InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 2InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 3InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 5EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 3
... June 08, 2007 /PRNewswire-FirstCall/ --,Lexicon Pharmaceuticals, Inc. today ... research project with scientists at Fox,Chase Cancer Center ... Lexicon researchers have discovered a novel and,surprising role ... T lymphocytes. These findings have been published in,the ...
... - NuPathe Inc., a,privately held specialty pharmaceutical ... Phase I study of NP101,SmartRelief, a novel ... NP101 combines NuPathe's SmartRelief(TM) proprietary,iontophoretic transdermal technology ... acute migraine in the United,States. Sumatriptan is ...
Cached Medicine Technology:Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune,Deficiency 2Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune,Deficiency 3NuPathe Reports Positive Phase One Results for NP101 Transdermal,Therapy for Acute Migraine 2NuPathe Reports Positive Phase One Results for NP101 Transdermal,Therapy for Acute Migraine 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: